CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.
about
CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@en
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@nl
type
label
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@en
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@nl
prefLabel
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@en
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@nl
P2093
P2860
P1476
CT Perfusion as an Early Bioma ...... ancer: An ACRIN and GOG Study.
@en
P2093
Chaan S Ng
Helga S Marques
Joan L Walker
John K Chan
Joseph Bauza
Kyle Burgers
Lainie P Martin
Michael A Bookman
Paul DiSilvestro
P2860
P304
P356
10.1158/1078-0432.CCR-16-1859
P407
P577
2017-02-07T00:00:00Z